MedTrace Logo

Effects of Mobility Dose in Surgical Intensive Care Unit Patients

NCT03196960 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-09-06

No results posted yet for this study

Summary

The primary aim of this study is to assess if the mobility dose that patients receive in the surgical intensive care unit (SICU) predicts adverse discharge disposition (primary endpoint), and muscle wasting diagnosed by bedside ultrasound (secondary endpoint).

Conditions

Sponsors & Collaborators

  • Technical University of Munich

    collaborator OTHER

  • Università degli Studi di Brescia

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Matthias Eikermann, MD PhD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-22
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States
  • Germany
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03196960 on ClinicalTrials.gov